Squarepoint Ops LLC Travere Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 28,562 shares of TVTX stock, worth $506,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,562

Previous 15,580 83.32%

Holding current value

$506,118

Previous $128,000 211.72%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.89 - $15.21 $102,427 - $197,456	12,982 Added 83.32%	28,562 $399,000
Q2 2024 Aug 14, 2024	SELL	$5.26 - $8.28 $44,662 - $70,305	-8,491 Reduced 35.27%	15,580 $128,000
Q1 2024 May 15, 2024	SELL	$7.18 - $9.82 $730,263 - $998,772	-101,708 Reduced 80.86%	24,071 $185,000
Q4 2023 Feb 14, 2024	SELL	$5.44 - $9.5 $187,783 - $327,930	-34,519 Reduced 21.53%	125,779 $1.13 Million
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $22,613 - $33,417	1,478 Added 0.93%	160,298 $2.46 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $2.58 Million - $3.31 Million	144,584 Added 1015.62%	158,820 $3.57 Million
Q4 2022 Feb 14, 2023	SELL	$18.47 - $26.14 $563,094 - $796,930	-30,487 Reduced 68.17%	14,236 $299,000
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $695,547 - $869,206	30,360 Added 211.38%	44,723 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$20.94 - $30.01 $300,761 - $431,033	14,363 New	14,363 $348,000
Q4 2021 Feb 14, 2022	SELL	$24.34 - $31.17 $318,099 - $407,360	-13,069 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $584,891 - $1.13 Million	-45,061 Reduced 77.52%	13,069 $317,000
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $389,732 - $729,194	27,621 Added 90.53%	58,130 $848,000
Q1 2021 May 17, 2021	BUY	$23.37 - $31.77 $315,401 - $428,767	13,496 Added 79.33%	30,509 $762,000
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $326,139 - $474,152	17,013 New	17,013 $464,000

Others Institutions Holding TVTX

# of Institutions

192

Shares Held

84.5M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.14B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Travere Therapeutics, Inc. Transaction History